comparemela.com

Latest Breaking News On - Dustin scaringe - Page 1 : comparemela.com

Accelerate Diagnostics, Inc (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript

Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.

United statesComunidad autonoma de catalunaJack phillipsWilliam blairAlex nowakDustin scaringeLaura piersonAndrew brackmannSecurities exchangeDiagnostics incAccelerate diagnosticsCall transcript marchAccelerate diagnostics fourth quarterFull yearSecurities actSecurities exchange act

Veracyte, Inc (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript

Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc.

United statesWilliam blairMarc stapleyShayla gormanDustin scaringeJi namMason carricoRebecca chambersMorgan stanleyExchange commissionResearch useSociety of urologic oncologyNational comprehensive cancer networkVeracyte incCall transcript februaryVeracyte fourth quarter

Exact Sciences Q2 Earnings Surpass Expectation, But Analyst Says Stock Has Limited Growth - Exact Sciences (NASDAQ:EXAS)

Exact Sciences Corp (NASDAQ: EXAS) reported Q2 revenue of $622 million, an increase of 19%, and $617 million of core revenue, an increase of 24%, beating the 

Bruce jacksonWilliam blairMaggie boeyeDustin scaringeAndrew brackmannSciences corpExact sciencesPrecision oncology

Invitae Corporation (NYSE:NVTA) Q4 2022 Earnings Call Transcript

Operator: Hello, everybody, and welcome to the Invitae Fourth Quarter 2020 Financial Results Conference Call. My name is Sam, and I will be coordinating your call today.

United statesJeffrey cohenKen kightHoki lukDustin scaringeAndrew brackmannKen knightMatthew sykesGabriella gabelWilliam blairInvitae corpMorgan stanleyInvitae corporationGoldman sachsCall transcript februaryInvitae fourth quarter

vimarsana © 2020. All Rights Reserved.